A61K 49/1866
The nanoparticle having a magnetic core coated or functionalised with a peptide
Official title: {the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid}
A61K49/1866 (The nanoparticle having a magnetic core coated or functionalised with a peptide) appears on 105 US grants and 183 published applications in this corpus.
Search patents in A61K- Granted patents
- 105
- Published applications
- 183
- Assignees
- 135
- Inventors
- 450
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 5 |
| 2003 | 4 | 5 |
| 2004 | 1 | 0 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 6 |
| 2008 | 0 | 5 |
| 2009 | 0 | 18 |
| 2010 | 0 | 17 |
| 2011 | 3 | 15 |
| 2012 | 2 | 9 |
| 2013 | 6 | 9 |
| 2014 | 7 | 10 |
| 2015 | 9 | 12 |
| 2016 | 7 | 11 |
| 2017 | 5 | 7 |
| 2018 | 2 | 8 |
| 2019 | 2 | 10 |
| 2020 | 7 | 8 |
| 2021 | 3 | 5 |
| 2022 | 6 | 5 |
| 2023 | 2 | 6 |
| 2024 | 3 | 4 |
| 2025 | 4 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof12 May 2026US 12,622,983 B2University of Massachusetts
- CAR peptide for improved coronavirus survival21 Apr 2026US 12,605,455 B2Vascular Biosciences
- Compounds and methods for the detection of TRPV-6 cancers and drug delivery4 Nov 2025US 12,458,618 B2Soricimed Biopharma Inc.
- Gelatin particles, method for producing gelatin particles, gelatin particle-containing cell, and method for producing gelatin particle-containing cell30 Sep 2025US 12,428,467 B2Konica Minolta, Inc.
- Compositions of and methods of making ferritin-based imaging agents8 Apr 2025US 12,268,760 B2Washington University
- All-in-one multimodal nanotheranostic platform for image-guided therapy20 Aug 2026US 2026/0241003 A1The Johns Hopkins University
- Multi-modal molecular imaging nanoprobe for early warning and dynamic monitoring of atherosclerotic plaques and use thereof23 Apr 2026US 2026/0108636 A1The Sixth Medical Center of Chinese Pla General Hospital
- Compositions of and methods of making ferritin-based imaging agents11 Dec 2025US 2025/0375545 A1Washington University
- Targeted delivery system and methods of use therefor27 Nov 2025US 2025/0361270 A1Sanford Burnham Prebys Medical Discovery Institute
- Magnetic ferroferric oxide nanoparticle, and preparation method therefor and use thereof2 Jan 2025US 2025/0001018 A1South Medical University
Most cited
By later US patents
- Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell193US 5,362,478 AVivorx Pharmaceuticals, Inc. · 1994
- Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging192US 5,505,932 AVivorx Pharmaceuticals, Inc. · 1996
- Non-fluorinated polymeric shells for medical imaging190US 5,508,021 AVivorx Pharmaceuticals, Inc. · 1996
- Method of magnetic resonance focused surgical and therapeutic ultrasound166US 6,088,613 AImaRx Pharmaceutical Corp. · 2000
- Percutaneous lymphography using particulate fluorocarbon emulsions165US 5,114,703 AAlliance Pharmaceutical Corp. · 1992